- Page 1: National Toxicology Program U.S. De
- Page 5 and 6: prefaCe The. National. Toxicology.
- Page 7 and 8: absTraCT NTP-CERHR MONOGRAPH ON THE
- Page 9 and 10: inTroduCTion Bisphenol.A.(CAS.RN:.8
- Page 12 and 13: Table of ConTenTs What.is.Bisphenol
- Page 14 and 15: nTp brief on bisphenol a WhaT is bi
- Page 16 and 17: Population Bisphenol A µg/kg bw/da
- Page 18 and 19: nTp brief Population Table 2. Urina
- Page 20 and 21: nTp brief and.growth.of.offspring.e
- Page 22 and 23: nTp brief A.related.to.neural.and.b
- Page 24 and 25: nTp brief of.laboratory.expertise,.
- Page 26 and 27: nTp brief to.be.quantified.in.the.b
- Page 28 and 29: nTp brief use.of.a.positive.control
- Page 30 and 31: nTp brief survival.and.growth.follo
- Page 32 and 33: nTp brief behavior.(116, 122, 143).
- Page 34 and 35: nTp brief (96).. In. brief,. estrad
- Page 36 and 37: nTp brief With.the.exception.of.an.
- Page 38 and 39: nTp brief treatment. was. not. sign
- Page 40 and 41: nTp brief considered.“positive”
- Page 42 and 43: nTp brief • Tyl.et al..(41).repor
- Page 44 and 45: nTp brief total. cholesterol,. trig
- Page 46 and 47: nTp brief Chromosome and Meiosis Ab
- Page 48 and 49: nTp brief ing.sources.of.exposure.(
- Page 50 and 51: nTp brief exPoSuRe ComPaRISoNS baSe
- Page 52 and 53:
nTp brief women.to.bisphenol.A.will
- Page 54 and 55:
nTp brief 60%.of.breast.milk.sample
- Page 56 and 57:
nTp brief higher,.as.much.as.~3000.
- Page 58 and 59:
nTp brief referenCes 1.. Wilson. NK
- Page 60 and 61:
nTp brief cessing.Aids.and.Material
- Page 62 and 63:
nTp brief 53.. Murray.TJ,.Maffini.M
- Page 64 and 65:
nTp brief activities.of.androgen.re
- Page 66 and 67:
nTp brief 106..Hiroi.H,.Tsutsumi,.O
- Page 68 and 69:
nTp brief natal. rat. bisphenol. A.
- Page 70 and 71:
nTp brief 159..Funabashi. T,. Kawag
- Page 72 and 73:
nTp brief 186..Russo.J,.Gusterson.B
- Page 74 and 75:
nTp brief and.developmental.paramet
- Page 76 and 77:
nTp brief 240..Parry. EM,. Parry. J
- Page 78 and 79:
[This page inTenTionally lefT blank
- Page 80 and 81:
Published 2008 Wiley-Liss, Inc. w E
- Page 82 and 83:
cumyl)phenol; 2,3-dihydro-3-(4 0 -h
- Page 84 and 85:
BISPHENOL A 161 Table 2 Concentrati
- Page 86 and 87:
BISPHENOL A Table 4 Continued Bisph
- Page 88 and 89:
BISPHENOL A Table 6 Surveys of Bisp
- Page 90 and 91:
emain in solution up to 20 hr when
- Page 92 and 93:
BISPHENOL A Table 7 Blood Concentra
- Page 94 and 95:
Country Study population BISPHENOL
- Page 96 and 97:
BISPHENOL A Table 10 Bisphenol A Or
- Page 98 and 99:
BISPHENOL A 175 Table 12 Average Es
- Page 100 and 101:
BISPHENOL A Table 14 Summary of Foo
- Page 102 and 103:
BISPHENOL A 179 Table 16 TWA Measur
- Page 104 and 105:
BISPHENOL A Table 19 Maximum Report
- Page 106 and 107:
BISPHENOL A Table 21 Saliva and Uri
- Page 108 and 109:
isphenol A. Bisphenol A was detecte
- Page 110 and 111:
in each group were killed at 96 hr
- Page 112 and 113:
Table 26 Toxicokinetic Endpoints fo
- Page 114 and 115:
Endpoint BISPHENOL A Table 30 Toxic
- Page 116 and 117:
BISPHENOL A Table 32 Toxicokinetic
- Page 118 and 119:
BISPHENOL A Table 34 Distribution o
- Page 120 and 121:
oute of elimination for radioactivi
- Page 122 and 123:
BISPHENOL A Table 42 Toxicokinetic
- Page 124 and 125:
isphenol A glucuronide (41% of the
- Page 126 and 127:
Table 44 Excretion of Radioactivity
- Page 128 and 129:
BISPHENOL A 205 lactate dehydrogena
- Page 130 and 131:
The European Union (2003) noted lim
- Page 132 and 133:
weight] included decreased heart we
- Page 134 and 135:
BISPHENOL A Table 52 In Vitro Estro
- Page 136 and 137:
BISPHENOL A Table 52 Continued Endp
- Page 138 and 139:
Model and exposure Husbandry a Adul
- Page 140 and 141:
Model and exposure Husbandry a Imma
- Page 142 and 143:
BISPHENOL A Fig. 2. In vitro estrog
- Page 144 and 145:
element. Eight hr after i.p. inject
- Page 146 and 147:
adioimmunoassay (RIA). Statistical
- Page 148 and 149:
Ivett et al. (1989) a,b Tennant et
- Page 150 and 151:
0.002, 0.02, and 2 mg/kg bw/day for
- Page 152 and 153:
* individuals with the SULT1A1 2 en
- Page 154 and 155:
BISPHENOL A Table 62 Continued Mode
- Page 156 and 157:
glucuronidating bisphenol A, and po
- Page 158 and 159:
Most in vivo estrogenicity studies
- Page 160 and 161:
BISPHENOL A 237 Table 70 Maternal a
- Page 162 and 163:
litter as the unit. It is unclear w
- Page 164 and 165:
group, as well as 19 offspring from
- Page 166 and 167:
In testes from 3-day-old rats, RT-P
- Page 168 and 169:
significance of the changes. Weakne
- Page 170 and 171:
N-methylurea were killed on PND 180
- Page 172 and 173:
parameters were examined at Day 30,
- Page 174 and 175:
study authors noted that no histori
- Page 176 and 177:
orn to 1 dam in that group died by
- Page 178 and 179:
Strengths/Weaknesses: Strengths of
- Page 180 and 181:
Student or Welch’s t-test using v
- Page 182 and 183:
cycles. The study authors concluded
- Page 184 and 185:
postnatal rearing. Pups were weaned
- Page 186 and 187:
slightly higher than environmental
- Page 188 and 189:
edding and caging materials. The Ex
- Page 190 and 191:
BISPHENOL A Table 73 Effects of Pub
- Page 192 and 193:
that 44.4% of prostates contained i
- Page 194 and 195:
injected with the tocopherol-stripp
- Page 196 and 197:
determine whether the changes in sp
- Page 198 and 199:
involved in cyclic AMP breakdown, w
- Page 200 and 201:
processes. The study authors noted
- Page 202 and 203:
BISPHENOL A 279 Table 75 Maternal a
- Page 204 and 205:
with 28 dams each were given the to
- Page 206 and 207:
utero and were 10% higher than body
- Page 208 and 209:
BISPHENOL A Table 77 Table 78 Effec
- Page 210 and 211:
6.5-13.5 days post-coitum and 6.5 t
- Page 212 and 213:
the studies. In each study, ddY mic
- Page 214 and 215:
glands were also conducted. Data we
- Page 216 and 217:
Technology, examined the effect of
- Page 218 and 219:
killed on GD 18 (plug 5 GD 0) for d
- Page 220 and 221:
and each treatment group was 36, 57
- Page 222 and 223:
Utility (Adequacy) for CERHR Evalua
- Page 224 and 225:
Endpoint b BISPHENOL A 301 Table 80
- Page 226 and 227:
3.2.8 Mouse—parenteral exposure p
- Page 228 and 229:
were culled to 10 pups/litter on PN
- Page 230 and 231:
Utility (Adequacy) for CERHR Evalua
- Page 232 and 233:
Results were reported to be similar
- Page 234 and 235:
isphenol A exposure on the developm
- Page 236 and 237:
457 lg/L] bisphenol A and malformat
- Page 238 and 239:
were no significant effects reporte
- Page 240 and 241:
Strengths/Weaknesses: This study is
- Page 242 and 243:
100 nM [23 ng/L], and 1 mM [0.23 mg
- Page 244 and 245:
BISPHENOL A Table 82 Summary of Hig
- Page 246 and 247:
BISPHENOL A Table 83 Summary of Lim
- Page 248 and 249:
Birth Defects Research (Part B) 83:
- Page 250 and 251:
Table 86 Adult Body Weights of Offs
- Page 252 and 253:
consistent effects on the levels of
- Page 254 and 255:
Hiroi et al. (2004), supported by t
- Page 256 and 257:
is not known if the sample numbers
- Page 258 and 259:
deciduoma formation in pseudopregna
- Page 260 and 261:
and left ovary weight in the mid-do
- Page 262 and 263:
social investigation, huddling, and
- Page 264 and 265:
[0.23 mg/L]. Bisphenol A dimethylac
- Page 266 and 267:
Experiment 1 2 3 4 5 BISPHENOL A 34
- Page 268 and 269:
Endpoint Relative organ weight Test
- Page 270 and 271:
Table 91 Effects in Rats Given Bisp
- Page 272 and 273:
BISPHENOL A Table 92 Effects Observ
- Page 274 and 275:
concluded that the testicular toxic
- Page 276 and 277:
oth] was significantly decreased at
- Page 278 and 279:
production at all dose levels, and
- Page 280 and 281:
are a primary (or secondary) effect
- Page 282 and 283:
Target intakes were B0, 0.0009, 0.0
- Page 284 and 285:
BISPHENOL A Table 93 Treatment-Rela
- Page 286 and 287:
Endpoint BISPHENOL A 363 Table 95 E
- Page 288 and 289:
Table 98 Treatment-Related Effects
- Page 290 and 291:
6/24 10/20 13/20 732 [124] 546 [92.
- Page 292 and 293:
1988 mg/kg bw/day in females during
- Page 294 and 295:
the 1.8 ppm group was not considere
- Page 296 and 297:
eproductive success were only 7-fol
- Page 298 and 299:
Multigeneration CD rat (gavaged wit
- Page 300 and 301:
0.0002 0.011 0.0082 0.0069 0.0050 0
- Page 302 and 303:
BISPHENOL A Table 104 Estimates of
- Page 304 and 305:
There is sufficient evidence in rat
- Page 306 and 307:
developmental endpoints that may be
- Page 308 and 309:
fish exposed to xenobiotics under c
- Page 310 and 311:
Hiroi H, Tsutsumi O, Momoeda M, Tak
- Page 312 and 313:
commercial resin-based dental resto
- Page 314 and 315:
ased composites and sealants used i
- Page 316 and 317:
Steinmetz R, Mitchner NA, Grant A,
- Page 318 and 319:
to pentachlorophenol, bisphenol-A,
- Page 320 and 321:
[This page inTenTionally lefT blank